Vakiener Victoria

Director at ARWR; Chief Commercial Officer at Epizyme, Inc.

Sold, on record
$1.2M
Dollars the filings state
Form 4 sales
7
Latest Dec 19, 2025
Form 144 notices
4
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ARWRNo plan
    Sep 28, 2023 2023

    Sold 1,550 shares at $26.33 ($41k)

    Vakiener Victoria, Director

    No 10b5-1 planSold 6.7% of holdings ($613k position)21,734 shares leftFirst sale on recordFollows a Form 144Filing

  2. 2 Form 144 notice ARWRNotice
    Jan 11, 2024 +105 days

    Filed to sell 4,720 shares ($180k)

    Vakiener Victoria, Officer

    10b5-1 planFiling

  3. 3 Form 4 sale ARWRRoutine
    Jan 11, 2024 same day

    Sold 4,720 shares at $38.10 ($180k)

    Vakiener Victoria, Director

    10b5-1 planSold 12.9% of holdings ($1.4M position)32,001 shares leftFollows a Form 144Filing

  4. 4 Form 144 notice ARWRNotice
    May 2, 2024 +112 days

    Filed to sell 1,799 shares ($42k)

    Vakiener Victoria, Officer

    10b5-1 planFiling

  5. 5 Form 4 sale ARWRRoutine
    May 2, 2024 same day

    Sold 1,799 shares at $23.31 ($42k)

    Vakiener Victoria, Director

    10b5-1 planSold 5.6% of holdings ($746k position)30,205 shares leftFollows a Form 144Filing

  6. 6 Form 144 notice ARWRNotice
    Dec 16, 2024 +228 days

    Filed to sell 8,994 shares ($197k)

    Vakiener Victoria, Director

    10b5-1 planFirst sale on recordFiling

  7. 7 Form 4 sale ARWRRoutine
    Dec 16, 2024 same day

    Sold 8,994 shares at $21.91 ($197k)

    Vakiener Victoria, Director

    10b5-1 planSold 29.8% of holdings ($662k position)21,211 shares leftFirst sale on recordFollows a Form 144Filing

  8. 8 Form 4 sale ARWRRoutine
    Dec 19, 2025 +368 days

    Sold 10,040 shares at $67.68 ($679k)

    Vakiener Victoria, Director

    10b5-1 planSold 21.9% of holdings ($3.1M position)35,723 shares left2.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Vakiener Victoria
Source
Dec 19, 2025Dec 23, 2025ARWRDirectorForm 4 sale10,040$679k21.9%RoutineSEC
Dec 16, 2024Dec 18, 2024ARWRDirectorForm 4 sale8,994$197k29.8%RoutineSEC
Dec 16, 2024Dec 16, 2024ARWRDirectorForm 144 notice8,994$197kNoticeSEC
May 2, 2024May 6, 2024ARWRDirectorForm 4 sale1,799$42k5.6%RoutineSEC
May 2, 2024May 2, 2024ARWROfficerForm 144 notice1,799$42kNoticeSEC
Jan 11, 2024Jan 16, 2024ARWRDirectorForm 4 sale4,720$180k12.9%RoutineSEC
Jan 11, 2024Jan 11, 2024ARWROfficerForm 144 notice4,720$180kNoticeSEC
Sep 28, 2023Oct 2, 2023ARWRDirectorForm 4 sale1,550$41k6.7%No planSEC
Sep 28, 2023Sep 28, 2023ARWROfficerForm 144 notice1,550$41kNoticeSEC
Feb 4, 2021Feb 5, 2021Epizyme, Inc.Chief Commercial OfficerForm 4 sale817$9k1.5%Plan not statedSEC
Jan 25, 2021Jan 27, 2021Epizyme, Inc.Chief Commercial OfficerForm 4 sale599$7k2.1%Plan not statedSEC